Advanced Tissue, LLC

CourtUnited States Bankruptcy Court, E.D. Arkansas
DecidedMarch 16, 2023
Docket4:21-bk-12261
StatusUnknown

This text of Advanced Tissue, LLC (Advanced Tissue, LLC) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, E.D. Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Advanced Tissue, LLC, (Ark. 2023).

Opinion

IN THE UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF ARKANSAS CENTRAL DIVISION

IN RE: ADVANCED TISSUE, LLC Case No. 4:21-bk-12261J (Chapter 11)

Debtor-in-Possession.

MEMORANDUM OPINION AND ORDER

Before the Court is the United States’ Motion for Determination Automatic Stay Does Not Apply or, in the Alternative, for Relief from the Automatic Stay to Set Off Mutual Debts (the “Motion”) (Doc. No. 189) filed by the United States of America, on behalf of the Department of Health and Human Services, acting through its designated component, the Centers for Medicare & Medicaid Services (“CMS”), on August 25, 2022. Advanced Tissue, LLC (the “Debtor”) filed a response to the Motion on September 14, 2022 (Doc. No. 195). The Motion and response were heard on October 11, 2022.1 CMS appeared through its counsel, Augustus T. Curtis with the United States Department of Justice, and Stacey E. McCord, Assistant U.S. Attorney. The Debtor appeared by and through its counsel, Kevin P. Keech of the Keech Law Firm, PA. At the close of the hearing, the Court took the matter under advisement. In the Motion, CMS asserts the Debtor received over $23 million in Medicare overpayments, and that CMS is entitled to recoup a portion of the overpayments against approximately $1.2 million in Medicare reimbursements that CMS is holding in a “Strumpf freeze.”2 Alternatively, CMS argues it is entitled to exercise its right of setoff against these frozen funds. For the reasons stated below, the Court finds CMS is entitled to recoup a portion

1 CMS expressly waived the thirty-day hearing requirement of 11 U.S.C. § 362(e)(1) in the Motion. 2 Out of an abundance of caution, the funds were frozen in accordance with the United States Supreme Court’s decision in Citizens Bank of Maryland v. Strumpf, 516 U.S. 16 (1995). of the overpayments against the frozen funds, and the automatic stay does not prevent CMS from doing so. I. Jurisdiction The Court has jurisdiction over this matter pursuant to 28 U.S.C. §§ 1334 and 157. See

also Fischbach v. Ctrs. for Medicare & Medicaid Servs. (In re Fischbach), No. 12-cv-00513, 2013 WL 1194850, at *2 (D.S.C. Mar. 22, 2013). This is a core proceeding pursuant to 28 U.S.C. § 157(b)(2)(A), (G), and (O). The following shall constitute the Court’s findings of fact and conclusions of law pursuant to Federal Rule of Bankruptcy Procedure 7052, made applicable to this contested matter by Federal Rules of Bankruptcy Procedure 4001 and 9014. II. Background Facts The facts before the Court are not in dispute.3 Prior to filing bankruptcy, from 2001 to June 18, 2021, the Debtor was enrolled as a Medicare Part B supplier. In its Medicare enrollment application, the Debtor’s representative agreed to abide by all Medicare laws and regulations and then made the following certification: “I agree that any existing or future

overpayment to me by the Medicare or other federal health care program(s) may be recouped by Medicare or other federal health care program(s) through withholding future payments.” (CMS Ex. A, at 11). On May 7, 2021, CMS notified the Debtor it was suspending Medicare reimbursements to the Debtor while it investigated “credible allegations of fraud.” (CMS Ex. B, at 1). Specifically, the suspension was based on information indicating the Debtor had misrepresented services billed to Medicare. As explained in the suspension letter, documentation submitted to Medicare did not support the type of supplies billed. The Debtor attempted to rebut the

3 At the hearing, the parties presented their cases on stipulated facts and exhibits. suspension, but CMS determined the suspension should remain in place pending its investigation. On or about June 18, 2021, the Debtor disenrolled from the Medicare program and ceased business operations. After disenrolling, the Debtor was not entitled to, and did not, bill Medicare for further goods or services.

On August 23, 2021, the Debtor filed its voluntary petition under Chapter 11 of the Bankruptcy Code. Both prior and subsequent to the bankruptcy filing, CMS Unified Program Integrity Contractors (“UPICs”) requested documents supporting the Debtor’s right to payment of claims identified in their investigations. Claims previously paid were reopened during the investigations. Some of the claims identified by the UPICs dated as far back as 2016. The Debtor provided some documentation in support of its claims in August and September 2021. The Debtor did not, however, provide documentation responsive to all the requests because it did not have sufficient staff to respond. In May 2022, the UPICs issued notices of their overpayment determinations, finding the Debtor had been overpaid $23,669,190.64 from 2016 through 2021. Many of these overpayment

determinations resulted from the Debtor’s failure to provide documentation in support of its claims. For example, one of the UPICs investigated claims submitted by the Debtor with dates of service from November 1, 2017, through August 30, 2021. It randomly selected thirty-five claims as a sample and requested medical records from the Debtor for these sample claims. The Debtor did not provide any medical records, which resulted in a 100% denial rate. This percentage was then extrapolated to all claims submitted by the Debtor in the particular region during the November 2017 through August 2021 timeframe, resulting in an overpayment determination of $3,408,679.01.4 (CMS Ex. H, at 24–34).

4 This methodology is in accordance with the Medicare statutes and regulations. See 42 U.S.C. § 1395ddd. In addition, even in instances where the Debtor did respond with medical records, many of its claims were similarly determined to be overpayments based on the records provided. For example, one of the UPICs investigated claims submitted by the Debtor with dates of service from March 31, 2016, through February 22, 2019. During the investigation, the Debtor

submitted medical records in support of the claims, but a determination was nevertheless made that the Debtor had been overpaid by $255,216.02 during this timeframe. (CMS Ex. H, at 16– 19). Again, the overpayment determinations made by the various UPICs totaled $23,669,190.64. There is no evidence in the record of an administrative appeal by the Debtor of any of the overpayment determinations.5 On May 20, 2022, when the overpayment determinations had been made, CMS lifted the regulatory suspension on the Medicare reimbursements it was holding and instead placed the funds into an administrative “Strumpf freeze.” At the time of the hearing, CMS was holding $1,220,224.27 in prepetition Medicare reimbursements claimed by the Debtor.

III. Arguments CMS argues it is entitled to recoup a portion of its overpayments to the Debtor against the administratively frozen funds because the two claims arise out of the same transaction. Alternatively, it argues it should be allowed to exercise its right of setoff against the frozen funds, and it seeks relief from stay to do so. The Debtor argues that neither recoupment nor setoff is appropriate.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Advanced Tissue, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/advanced-tissue-llc-areb-2023.